---
figid: PMC7411076__fendo-11-00505-g0002
figlink: pmc/articles/PMC7411076/figure/F2/
number: Figure 2
caption: Pharmacological inhibition of de novo ceramide synthesis prevents high fat
  diet (HFD) induced NASH. (A) Simplified schematic of ceramide de novo synthesis
  pathway, demonstrating the target of Myriocin (in red). (B) Graphical summary of
  the beneficial effects of Myriocin treatment in HFD-fed Sprague-Dawley rats. HFD-induced
  NAFLD related effects are shown in black with the beneficial effects of Myriocin
  treatments shown with red lines. Figure was created with BioRender.com.
pmcid: PMC7411076
papertitle: Too Much of a Good Thing? An Evolutionary Theory to Explain the Role of
  Ceramides in NAFLD.
reftext: Annelise M. Poss, et al. Front Endocrinol (Lausanne). 2020;11:505.
pmc_ranked_result_index: '42482'
pathway_score: 0.9352092
filename: fendo-11-00505-g0002.jpg
figtitle: Pharmacological inhibition of de novo ceramide synthesis prevents high fat
  diet (HFD) induced NASH
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7411076__fendo-11-00505-g0002.html
  '@type': Dataset
  description: Pharmacological inhibition of de novo ceramide synthesis prevents high
    fat diet (HFD) induced NASH. (A) Simplified schematic of ceramide de novo synthesis
    pathway, demonstrating the target of Myriocin (in red). (B) Graphical summary
    of the beneficial effects of Myriocin treatment in HFD-fed Sprague-Dawley rats.
    HFD-induced NAFLD related effects are shown in black with the beneficial effects
    of Myriocin treatments shown with red lines. Figure was created with BioRender.com.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TNF
  - IL18
  - IL6
  - Myriocin
  - palmitoyl
  - CoA
  - serine
  - triglyceride
  - 'N'
  - 3-ketosphinganine
  - ceramides
  - sphinganine
  - dihydroceramide
  - ceramide
genes:
- word: TNF-a,
  symbol: TNFA
  source: hgnc_prev_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: IL-18
  symbol: IL-18
  source: hgnc_alias_symbol
  hgnc_symbol: IL18
  entrez: '3606'
- word: IL-6,
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: IL-6,TNF-a,IL-18
  symbol: IL-18
  source: hgnc_alias_symbol
  hgnc_symbol: IL18
  entrez: '3606'
- word: IL-6,TNF-a,IL-18
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: IL-6,TNF-a,IL-18
  symbol: TNFA
  source: hgnc_prev_symbol
  hgnc_symbol: TNF
  entrez: '7124'
chemicals:
- word: Myriocin
  source: MESH
  identifier: C001996
- word: palmitoyl
  source: MESH
  identifier: C032023
- word: CoA
  source: MESH
  identifier: C065987
- word: serine
  source: MESH
  identifier: C047902
- word: triglyceride
  source: MESH
  identifier: D014280
- word: 'N'
  source: MESH
  identifier: D009584
- word: 3-ketosphinganine
  source: MESH
  identifier: C002882
- word: ceramides
  source: MESH
  identifier: D002518
- word: sphinganine
  source: MESH
  identifier: C005682
- word: dihydroceramide
  source: MESH
  identifier: C109343
- word: ceramide
  source: MESH
  identifier: D002518
diseases: []
---
